Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhaoming Li

Showing results (91-100 of 136) with videos related to

Pageof 14
Sort By:
ACS Applied Materials & Interfaces|June 17, 2025
Dual-Strategy Pullulan-Soluble Microneedles Based on LL37@ZIF-8 and Artificial Nanozyme Antioxidation for Infected Wound HealingLijie Wang, Zixuan Wang, Jiarong Chang, et al.
Scientific Reports|January 20, 2018
Patients over 40 years old with precursor T-cell lymphoblastic lymphoma have different prognostic factors comparing to the youngersMeng Dong, Xudong Zhang, Zhenzhen Yang, et al.
Oncotarget|August 13, 2016
The DDGP (cisplatin, dexamethasone, gemcitabine, and pegaspargase) regimen for treatment of extranodal natural killer (NK)/T-cell lymphoma, nasal typeLei Zhang, Sucai Li, Sisi Jia, et al.
Oncotarget|October 27, 2017
Discovery and validation of the tumor-suppressive function of long noncoding RNA PANDA in human diffuse large B-cell lymphoma through the inactivation of MAPK/ERK signaling pathwayYingjun Wang, Mingzhi Zhang, Huanan Xu, et al.
Medicine|July 21, 2017
Phosphatase and tensin homolog (PTEN) is down-regulated in human NK/T-cell lymphoma and corrects with clinical outcomesXiaorui Fu, Xudong Zhang, Jinli Gao, et al.
Cell Death & Disease|May 28, 2026
LCP2 mediates SUV39H1-driven cellular senescence-related chemoresistance in natural killer/T-cell lymphomaYue Zhang, Siyu Qian, Qing Yang, et al.
Cancer Biology & Therapy|October 10, 2018
MiRNA-155 regulates lymphangiogenesis in natural killer/T-cell lymphoma by targeting BRG1Yu Chang, Meng Cui, Xiaorui Fu, et al.
Oncology Letters|September 10, 2014
Role of programmed death ligands in effective T-cell interactions in extranodal natural killer/T-cell lymphomaLijuan Han, Feifei Liu, Ruping Li, et al.
International Journal of Molecular Medicine|May 14, 2011
hSav1 interacts with HAX1 and attenuates its anti-apoptotic effects in MCF-7 breast cancer cellsXuelai Luo, Zhaoming Li, Xiaolan Li, et al.
Journal of Cellular and Molecular Medicine|November 29, 2018
One method to establish Epstein-Barr virus-associated NK/T cell lymphoma mouse modelsWeili Xue, Weiming Li, Yufeng Shang, et al.
Pageof 14

Showing results (91-100 of 136) with videos related to

Sort By:
Pageof 14
ACS Applied Materials & Interfaces|June 17, 2025
Dual-Strategy Pullulan-Soluble Microneedles Based on LL37@ZIF-8 and Artificial Nanozyme Antioxidation for Infected Wound HealingLijie Wang, Zixuan Wang, Jiarong Chang, et al.
Scientific Reports|January 20, 2018
Patients over 40 years old with precursor T-cell lymphoblastic lymphoma have different prognostic factors comparing to the youngersMeng Dong, Xudong Zhang, Zhenzhen Yang, et al.
Oncotarget|August 13, 2016
The DDGP (cisplatin, dexamethasone, gemcitabine, and pegaspargase) regimen for treatment of extranodal natural killer (NK)/T-cell lymphoma, nasal typeLei Zhang, Sucai Li, Sisi Jia, et al.
Oncotarget|October 27, 2017
Discovery and validation of the tumor-suppressive function of long noncoding RNA PANDA in human diffuse large B-cell lymphoma through the inactivation of MAPK/ERK signaling pathwayYingjun Wang, Mingzhi Zhang, Huanan Xu, et al.
Medicine|July 21, 2017
Phosphatase and tensin homolog (PTEN) is down-regulated in human NK/T-cell lymphoma and corrects with clinical outcomesXiaorui Fu, Xudong Zhang, Jinli Gao, et al.
Cell Death & Disease|May 28, 2026
LCP2 mediates SUV39H1-driven cellular senescence-related chemoresistance in natural killer/T-cell lymphomaYue Zhang, Siyu Qian, Qing Yang, et al.
Cancer Biology & Therapy|October 10, 2018
MiRNA-155 regulates lymphangiogenesis in natural killer/T-cell lymphoma by targeting BRG1Yu Chang, Meng Cui, Xiaorui Fu, et al.
Oncology Letters|September 10, 2014
Role of programmed death ligands in effective T-cell interactions in extranodal natural killer/T-cell lymphomaLijuan Han, Feifei Liu, Ruping Li, et al.
International Journal of Molecular Medicine|May 14, 2011
hSav1 interacts with HAX1 and attenuates its anti-apoptotic effects in MCF-7 breast cancer cellsXuelai Luo, Zhaoming Li, Xiaolan Li, et al.
Journal of Cellular and Molecular Medicine|November 29, 2018
One method to establish Epstein-Barr virus-associated NK/T cell lymphoma mouse modelsWeili Xue, Weiming Li, Yufeng Shang, et al.
Pageof 14